Package 82009-040-90

Brand: valacyclovir

Generic: valacyclovir
NDC Package

Package Facts

Identity

Package NDC 82009-040-90
Digits Only 8200904090
Product NDC 82009-040
Description

90 TABLET, FILM COATED in 1 BOTTLE (82009-040-90)

Marketing

Marketing Status
Marketed Since 2022-10-14
Brand valacyclovir
Generic valacyclovir
Sample Package No

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "48e59181-d597-f69b-e063-6294a90ad434", "openfda": {"upc": ["0382009040301", "0382009041902"], "unii": ["G447S0T1VC"], "rxcui": ["313564", "313565"], "spl_set_id": ["764b0cf9-9207-404c-87a8-a1e0109af6cc"], "manufacturer_name": ["Quallent Pharmaceuticals Health LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "90 TABLET, FILM COATED in 1 BOTTLE (82009-040-90)", "package_ndc": "82009-040-90", "marketing_start_date": "20221014"}], "brand_name": "Valacyclovir", "product_id": "82009-040_48e59181-d597-f69b-e063-6294a90ad434", "dosage_form": "TABLET, FILM COATED", "pharm_class": ["DNA Polymerase Inhibitors [MoA]", "Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Nucleoside Analog [EXT]"], "product_ndc": "82009-040", "generic_name": "Valacyclovir", "labeler_name": "Quallent Pharmaceuticals Health LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Valacyclovir", "active_ingredients": [{"name": "VALACYCLOVIR HYDROCHLORIDE", "strength": "500 mg/1"}], "application_number": "ANDA203047", "marketing_category": "ANDA", "marketing_start_date": "20221014", "listing_expiration_date": "20271231"}